Mark Applebaum, MD, assistant professor of pediatrics, is an expert in childhood cancers and blood diseases. He has a special interest in the treatment of neuroblastoma, sarcomas and solid tumors.
Through this research, Dr. Applebaum has helped develop risk-based guidelines for long-term follow-up of childhood and adolescent cancer survivors for subsequent malignant neoplasms and other adverse health outcomes based on the primary disease, treatment exposure, and established therapy-related morbidities and mortality observed in the survivorship population.
Jane E. Churpek, MD, assistant professor of medicine, is researching the inherited genetic factors that make individuals at risk for developing blood cancers (hematologic malignancies) and bone marrow disorders, and is working to develop ways to detect these diseases early, and ultimately, prevent them.
She also helps individuals and their families understand their risk of developing cancer and ways they can reduce these risks. Dr. Churpek serves as the primary investigator on multiple studies designed to investigate the genes that may increase an individual’s risk of developing cancer.
Nita Karnik Lee, MD, PhD, assistant professor of obstetrics/gynecology, specializes in the diagnosis and treatment of women with gynecologic malignancies.
Her research interests include cancer survivorship, cancer disparities, and clinical trials focusing on new therapies for ovarian, uterine and cervical cancers. She is an active member of the Gynecologic Oncology Group (GOG), a cooperative research group supported by the National Cancer Institute.